Last Price
3.55
Today's Change
-0.20 (5.33%)
Day's Change
3.47 - 3.79
Trading Volume
688,793
Market Cap
426 Million
Shares Outstanding
120 Million
Avg Volume
762,264
Avg Price (50 Days)
4.95
Avg Price (200 Days)
6.57
PE Ratio
-1.64
EPS
-2.17
Earnings Announcement
01-Nov-2024
Previous Close
3.75
Open
3.72
Day's Range
3.47 - 3.79
Year Range
3.47 - 13.273
Trading Volume
692,167
1 Day Change
-5.33%
5 Day Change
-19.32%
1 Month Change
-19.32%
3 Month Change
-45.97%
6 Month Change
-56.39%
Ytd Change
-59.47%
1 Year Change
-71.20%
3 Year Change
-76.90%
5 Year Change
-76.90%
10 Year Change
-76.90%
Max Change
-76.90%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.